AQEMIA

Paris, France · Founded 2019 · Privately Held (backing)

Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. AQEMIA is based in Paris, France and was founded in 2019. Its last reported valuation was $244 million in Dec 2024. It has raised $69.5 million.

Last reported valuation
$243.6M
Oct 2026
Priced at
—
Total raised
$69.5M
Last round
—

Who backs AQEMIA?

12 investors
InvestorType
BpifranceOther
La French TechOther
AgoranovOther
Cathay InnovationVenture capital
Cathay CapitalPE / buyout
Elaia PartnersVenture capital
Idinvest PartnersPE / buyout
Wendel GroupFamily office
BioIndustry Association—
Deeptech Founders—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AQEMIA investors

12 investors are on record for AQEMIA, including Bpifrance, La French Tech, Agoranov and Cathay Innovation.

Free account
More of AQEMIA with a free account
  • ·The complete investor list: 12 names
  • ·Watch AQEMIA: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like AQEMIA. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View